Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy

  • Xiang Zheng
    Max Planck Institute for Heart and Lung Research, Department of Lung Development and Remodeling, Member of the German Center for Lung Research (DZL), Bad Nauheim, Germany
  • Kati Turkowski
    Max Planck Institute for Heart and Lung Research, Department of Lung Development and Remodeling, Member of the German Center for Lung Research (DZL), Bad Nauheim, Germany
  • Javier Mora
    Institute of Biochemistry I, Goethe-University Frankfurt, Frankfurt, Germany
  • Bernhard Brüne
    Institute of Biochemistry I, Goethe-University Frankfurt, Frankfurt, Germany
  • Werner Seeger
    Max Planck Institute for Heart and Lung Research, Department of Lung Development and Remodeling, Member of the German Center for Lung Research (DZL), Bad Nauheim, Germany
  • Andreas Weigert
    Institute of Biochemistry I, Goethe-University Frankfurt, Frankfurt, Germany
  • Rajkumar Savai
    Max Planck Institute for Heart and Lung Research, Department of Lung Development and Remodeling, Member of the German Center for Lung Research (DZL), Bad Nauheim, Germany

収録刊行物

  • Oncotarget

    Oncotarget 8 (29), 48436-48452, 2017-04-12

    Impact Journals, LLC

被引用文献 (7)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ